ETF Holdings Breakdown of CRL

Stock NameCreightons Plc
TickerCRL(GBX) LSE
TYPECommon Stock
CountryUK
ISINGB0002341666
LEI213800WROWAJUBGSAJ57

News associated with CRL

Assetmark Inc. Has $1.80 Million Position in Charles River Laboratories International, Inc. (NYSE:CRL)
Assetmark Inc. grew its position in Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 5,099.5% during the 4th quarter, Holdings Channel reports. The firm owned 9,775 shares of the medical research company’s stock after purchasing an additional 9,587 shares during the quarter. Assetmark Inc.’s holdings in Charles River Laboratories International were worth $1,804,000 […] - 2025-03-11 08:20:57
Charles Schwab Investment Management Inc. Boosts Position in Charles River Laboratories International, Inc. (NYSE:CRL)
Charles Schwab Investment Management Inc. boosted its position in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 7.3% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 552,975 shares of the medical research company’s stock after acquiring an additional […] - 2025-03-10 08:44:49
1,382 Shares in Charles River Laboratories International, Inc. (NYSE:CRL) Acquired by QRG Capital Management Inc.
QRG Capital Management Inc. bought a new position in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) during the 4th quarter, HoldingsChannel reports. The institutional investor bought 1,382 shares of the medical research company’s stock, valued at approximately $255,000. Other hedge funds have also added to or reduced their stakes in the […] - 2025-03-07 09:30:55
Charles River Laboratories International, Inc. (NYSE:CRL) Receives $198.36 Consensus Price Target from Brokerages
Charles River Laboratories International, Inc. (NYSE:CRL – Get Free Report) has received an average recommendation of “Hold” from the sixteen brokerages that are covering the company, MarketBeat reports. One analyst has rated the stock with a sell rating, fourteen have given a hold rating and one has given a buy rating to the company. The […] - 2025-03-07 08:38:58
Charles River Laboratories International (NYSE:CRL) Stock Rating Upgraded by Redburn Atlantic
Charles River Laboratories International (NYSE:CRL – Get Free Report) was upgraded by research analysts at Redburn Atlantic from a “sell” rating to a “neutral” rating in a report issued on Monday, Marketbeat reports. The brokerage presently has a $188.00 target price on the medical research company’s stock. Redburn Atlantic’s target price would suggest a potential […] - 2025-03-05 07:04:54
Insiders Pile Into Holdings of FTXH ETF
A look at the weighted underlying holdings of the First Trust Nasdaq Pharmaceuticals ETF (FTXH) shows an impressive 23.8% of holdings on a weighted basis have experienced insider buying within the past six months. Charles River Laboratories International Inc. (Symbol: CRL), wh - 2025-02-26 14:32:53
Charles River Laboratories International (NYSE:CRL) Shares Up 3.9% on Insider Buying Activity
Charles River Laboratories International, Inc. (NYSE:CRL – Get Free Report)’s stock price rose 3.9% during trading on Monday after an insider bought additional shares in the company. The stock traded as high as $172.45 and last traded at $169.45. Approximately 274,567 shares were traded during trading, a decline of 73% from the average daily volume […] - 2025-02-25 06:05:00
Charles River Laboratories International (NYSE:CRL) Shares Gap Up After Better-Than-Expected Earnings
Charles River Laboratories International, Inc. (NYSE:CRL – Get Free Report) shares gapped up before the market opened on Wednesday after the company announced better than expected quarterly earnings. The stock had previously closed at $154.39, but opened at $159.28. Charles River Laboratories International shares last traded at $160.76, with a volume of 152,366 shares changing […] - 2025-02-21 06:56:44
Barclays Cuts Charles River Laboratories International (NYSE:CRL) Price Target to $166.00
Charles River Laboratories International (NYSE:CRL – Get Free Report) had its price target cut by equities research analysts at Barclays from $205.00 to $166.00 in a report issued on Tuesday,Benzinga reports. The brokerage currently has an “equal weight” rating on the medical research company’s stock. Barclays‘s price target indicates a potential upside of 0.61% from […] - 2025-02-20 06:58:45
Charles River Laboratories Q4 24 Earnings Conference Call At 8:30 AM ET
(RTTNews) - Charles River Laboratories International Inc. (CRL) will host a conference call at 8:30 AM ET on February 19, 2025, to discuss Q4 24 earnings results. - 2025-02-19 12:31:18
Charles River Laboratories International, Inc. (NYSE:CRL) Shares Sold by New York State Teachers Retirement System
New York State Teachers Retirement System decreased its holdings in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 11.8% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 45,230 shares of the medical research company’s stock after selling […] - 2025-02-19 10:44:53
Charles River Laboratories International, Inc. (NYSE:CRL) Stock Position Decreased by Louisiana State Employees Retirement System
Louisiana State Employees Retirement System cut its position in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 3.4% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,800 shares of the medical research company’s stock after selling 100 […] - 2025-02-19 10:10:54
Charles River Laboratories International, Inc. (NYSE:CRL) Shares Bought by V Square Quantitative Management LLC
V Square Quantitative Management LLC raised its position in Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 12.6% during the 4th quarter, according to its most recent filing with the SEC. The firm owned 1,084 shares of the medical research company’s stock after buying an additional 121 shares during the quarter. V Square […] - 2025-02-18 09:28:57
Chevy Chase Trust Holdings LLC Reduces Position in Charles River Laboratories International, Inc. (NYSE:CRL)
Chevy Chase Trust Holdings LLC decreased its holdings in Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 3.1% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 26,834 shares of the medical research company’s stock after selling 849 shares during […] - 2025-02-18 08:44:51
Van ECK Associates Corp Has $8.93 Million Position in Charles River Laboratories International, Inc. (NYSE:CRL)
Van ECK Associates Corp lowered its stake in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 5.6% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 48,380 shares of the medical research company’s stock after selling 2,893 shares during the quarter. […] - 2025-02-17 08:49:11
Charles River Laboratories International, Inc. (NYSE:CRL) Shares Sold by Stratos Wealth Partners LTD.
Stratos Wealth Partners LTD. decreased its holdings in Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 17.1% in the fourth quarter, HoldingsChannel.com reports. The firm owned 1,523 shares of the medical research company’s stock after selling 314 shares during the quarter. Stratos Wealth Partners LTD.’s holdings in Charles River Laboratories International were worth […] - 2025-02-14 09:00:50
abrdn plc Reduces Stock Holdings in Charles River Laboratories International, Inc. (NYSE:CRL)
abrdn plc cut its stake in Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 5.5% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 17,817 shares of the medical research company’s stock after selling 1,027 shares during the quarter. abrdn plc’s […] - 2025-02-10 18:43:00
Charles River Laboratories International, Inc. (NYSE:CRL) Shares Sold by Mather Group LLC.
Mather Group LLC. cut its holdings in Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 20.3% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 358 shares of the medical research company’s stock after selling 91 shares during the quarter. Mather […] - 2025-02-08 08:44:51
Charles River Laboratories International, Inc. (NYSE:CRL) Receives Average Rating of “Reduce” from Analysts
Shares of Charles River Laboratories International, Inc. (NYSE:CRL – Get Free Report) have been assigned a consensus recommendation of “Reduce” from the seventeen analysts that are covering the firm, MarketBeat.com reports. Three research analysts have rated the stock with a sell rating, thirteen have given a hold rating and one has given a buy rating […] - 2025-02-07 08:28:37
Tokio Marine Asset Management Co. Ltd. Buys 485 Shares of Charles River Laboratories International, Inc. (NYSE:CRL)
Tokio Marine Asset Management Co. Ltd. increased its stake in Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 24.5% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 2,463 shares of the medical research company’s stock after purchasing an additional […] - 2025-02-05 08:48:53
Charles River Laboratories International, Inc. (NYSE:CRL) Short Interest Up 5.6% in January
Charles River Laboratories International, Inc. (NYSE:CRL – Get Free Report) saw a large increase in short interest during the month of January. As of January 15th, there was short interest totalling 2,260,000 shares, an increase of 5.6% from the December 31st total of 2,140,000 shares. Based on an average daily volume of 667,300 shares, the […] - 2025-02-03 06:32:58
1,282 Shares in Charles River Laboratories International, Inc. (NYSE:CRL) Bought by Flagship Harbor Advisors LLC
Flagship Harbor Advisors LLC purchased a new stake in Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm purchased 1,282 shares of the medical research company’s stock, valued at approximately $237,000. Several other institutional investors have also […] - 2025-01-30 09:43:30

CRL institutional holdings

The following institutional investment holdings of CRL have been identified

Date ETF ISIN/Name Num Shares Book value
2025-03-10 IE00B5BMR087 (iShares Core S&P 500 UCITS ETF USD (Acc)) 116,123USD 20,335,460 -0.5%
2025-03-10 IE00BD8KRH84 (iShares Core S&P 500 UCITS ETF) 116,123USD 20,335,460 -0.5%
2025-03-10 IE00BL3J3G74 (iShares Core S&P 500 UCITS ETF MXN Hedged (Acc)) 116,123USD 20,335,460 -0.5%
2025-02-27 IE00B4L5Y983 (iShares Core MSCI World UCITS ETF USD (Acc)) 68,228USD 11,249,433 -1.9%
2025-02-27 IE00BD45YS76 (iShares Core MSCI World UCITS ETF GBP Hedged (Dist)) 68,228USD 11,249,433 -1.9%
2025-02-27 IE00BKBF6H24 (iShares Core MSCI World UCITS ETF EUR Hedged (Dist)) 68,228USD 11,249,433 -1.9%
2025-02-27 IE000OHHIBC6 (iShares Core MSCI World UCITS ETF) 68,228USD 11,249,433 -1.9%
2025-02-27 IE00BHZPJ890 (iShares MSCI USA ESG Enhanced UCITS ETF USD Inc GBP) 10,092 -0.2%USD 1,663,969 -2.1%
2025-03-10 IE0031442068 (iShares Core S&P 500 UCITS ETF USD Dist) 18,980 -0.1%USD 3,323,778 -0.6%
2025-02-27 IE00B6R52259 (iShares MSCI ACWI UCITS ETF) 8,869USD 1,462,321 -1.9%
2025-02-27 IE00BFNM3G45 (iShares MSCI USA ESG Screened UCITS ETF USD (Acc) GBP) 12,805 -0.1%USD 2,111,288 -2.0%
2025-02-27 IE00BFNM3H51 (iShares IV Public Limited Company - iShares MSCI USA ESG Screened UCITS ETF) 12,805 -0.1%USD 2,111,288 -2.0%
2025-02-27 IE000G2LIHG9 (ISHETFSAUAIMETFP) 12,805 -0.1%USD 2,111,288 -2.0%
2024-11-18 IE00BMTX1Y45 (iShares S&P 500 Swap UCITS ETF) 5,730 195.5%USD 1,074,375 212.4%
2024-11-18 IE000D3BWBR2 (ISH S&P 500 SWP US) 5,730 195.5%USD 1,074,375 212.4%
2025-02-27 IE00B0M62Q58 (iShares Public Limited Company - iShares MSCI World UCITS ETF) 4,620USD 761,746 -1.9%
2025-03-10 IE00B3ZW0K18 (iShares V plc - iShares S&P 500 EUR Hedged UCITS ETF Acc) 7,580 -0.4%USD 1,224,830 -0.6%
2025-02-27 IE00BHZPJ569 (iShares MSCI World ESG Enhanced UCITS ETF USD Acc GBP) 1,024USD 168,837 -1.9%
2025-02-27 IE00BG11HV38 (iShares MSCI World ESG Enhanced UCITS ETF USD Inc GBP) 1,024USD 168,837 -1.9%
2025-02-27 IE00BFNM3K80 (iShares IV Public Limited Company - iShares MSCI World ESG Screened UCITS ETF) 4,019USD 662,653 -1.9%
2025-02-27 IE00BFNM3J75 (iShares MSCI World ESG Screened UCITS ETF USD (Acc)) 4,019USD 662,653 -1.9%
2025-03-10 IE0003WV2ME7 (iShares S&P 500 Equal Weight UCITS ETF GBP Hedged (Acc)) 58,557USD 10,254,502 -0.5%
2025-03-10 IE000MLMNYS0 (iShares S&P 500 Equal Weight UCITS ETF) 58,557USD 10,254,502 -0.5%
2024-11-12 IE00B441G979 (iShares MSCI World EUR Hedged UCITS ETF Acc) 2,748 0.4%USD 559,313 -1.4%
2025-03-10 IE00B43HR379 (iShares S&P 500 Health Care Sector UCITS ETF USD (Acc) GBP) 23,500USD 4,115,320 -0.5%
2025-03-10 IE00BMBKBZ46 (iShares S&P 500 Health Care Sector UCITS ETF) 23,500USD 4,115,320 -0.5%
2025-02-27 IE00B52SFT06 (iShares VII Public Limited Company - iShares MSCI USA UCITS ETF) 1,806USD 297,773 -1.9%
2025-02-27 IE00B14X4M10 (iShares Public Limited Company - iShares MSCI North America UCITS ETF) 1,166USD 192,250 -1.9%
2025-03-10 IE00BYZK4776 (iShares Healthcare Innovation UCITS ETF USD (Acc)) 70,338USD 12,317,591 -0.5%
2025-02-27 IE00BJ5JNZ06 (iShares MSCI World Health Care Sector ESG UCITS ETF) 994USD 163,891 -1.9%
2024-11-12 IE0009QS7W62 (MSCI Wld Hlth US A) 1,272USD 274,676
2025-03-10 IE00B3Y8X563 (iShares V Public Limited Company - iShares S&P 500 GBP Hedged UCITS ETF) 1,104USD 149,829 -0.3%
2025-03-10 IE000R9FA4A0 (iShares S&P 500 ESG UCITS ETF USD (Acc)) 830 -0.5%USD 145,350 -0.9%
2025-02-27 IE00B42YS929 (iShares MSCI World GBP Hedged UCITS ETF Acc) 267USD 34,861 -1.3%
2025-02-27 IE00BP3QZD73 (iShares IV Public Limited Company - iShares Edge MSCI World Size Factor UCITS ETF) 1,706USD 281,285 -1.9%
2025-02-27 IE00BD1F4K20 (iShares IV Public Limited Company - iShares Edge MSCI USA Size Factor UCITS ETF) 4,790USD 789,775 -1.9%
2025-03-10 IE0002EKOXU6 (iShares Russell 1000 Value UCITS ETF) 237USD 41,503 -0.5%
2025-02-27 IE000YNE6S57 (ISHETF756290XAMS) 9USD 1,484 -1.9%
2025-02-27 IE0001YGXFO5 (ISHETF756290XAMS) 9USD 1,484 -1.9%
2025-02-27 IE000YG82CF0 (ISHETF756292XAMS) 7USD 1,154 -1.9%
2025-02-27 IE000MGAVJV3 (ISHETF756292XAMS) 7USD 1,154 -1.9%
2025-02-27 IE00019GPKX6 (iShares MSCI ACWI UCITS ETF SGD Hedged (Acc)) 8,869USD 1,462,321 -1.9%
2024-11-08 IE000X08RX14 (iShares MSCI World ESG Enhanced UCITS ETF NZD Hedged (Acc)) 958USD 206,344 2.4%
2025-03-10 IE00BF4RFH31 (Ishares III PLC - Ishares Msci World Small Cap UCITS ETF) 29,520USD 5,169,542 -0.5%
2024-12-10 IE00B3VWMM18 (iShares VII Public Limited Company - iShares MSCI EMU Small Cap UCITS ETF) 96,424EUR 1,860,983 1.2%
2025-03-10 IE00B3VWM098 (iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc) 29,728USD 5,205,967 -0.5%
2025-03-10 IE000T9EOCL3 (iS Wor ESG En Acc) 587USD 102,795 -0.5%
Total =1,148,873 USD 182,587,319
Book value of shares is calculated on the adjusted close price of each day (row).

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.